siluntai acipimox capsules hypertriglyceridemia mixed hyperlipidemia 0

Description

Indication & Scope

SiLunTai® Acipimox Capsules treats hypertriglyceridemia and mixed hyperlipidemia. It is used as an alternative lipid-lowering therapy for patients who cannot tolerate statin or fibrate lipid-lowering drugs.

Mechanism: Acipimox inhibits lipolysis in adipose tissue, reduces free fatty acid release into the liver, inhibits hepatic triglyceride synthesis and very low-density lipoprotein secretion, thereby significantly reducing serum triglyceride levels and moderately lowering total cholesterol and low-density lipoprotein levels.
Drug class: Nicotinic Acid Derivative Lipid-lowering Agent.
Clinical use: Clinically used for the treatment of moderate to severe hypertriglyceridemia and mixed hyperlipidemia, especially for patients with statin or fibrate intolerance, to regulate blood lipid levels and reduce atherosclerotic cardiovascular disease risk.

Specification

Generic Name	Acipimox Capsules
Brand Name	SiLunTai
Ingredient	Acipimox
Dosage Form	Capsules
Package	0.25g*30 capsules/box
Conditions Treated	Hypertriglyceridemia, mixed hyperlipidemia
Taboos	Contraindicated in patients with hypersensitivity to acipimox, severe peptic ulcer disease, acute liver and kidney dysfunction, and pregnant and lactating women
Place of origin	China
Prescription type	Prescription-only
Storage Conditions	Store sealed at room temperature, keep dry and avoid direct sunlight and high temperature environment
Manufacturer	Zhejiang Thermo Pharmaceutical Co., Ltd.
Registration Authority	National Medical Products Administration (NMPA), China
Approval number	H20249501
Approval Date	Dec 1, 2024
Shelf Life	24 months

How to use ?

Recommended Dose: The conventional dose is one capsule three times a day, taken after meals. The dosage can be adjusted according to blood lipid test results under medical guidance.

Time: Take orally after three meals every day to reduce gastrointestinal irritation.

Instructions for use: Take the capsule whole with warm water after meals. Do not open or chew the capsule content. Regular blood lipid, liver and kidney function rechecks are required during treatment.

Interaction: Combined use with statins or fibrates may increase the risk of myalgia and rhabdomyolysis. Concomitant use with antihypertensive drugs has no obvious adverse interaction. Combined with anticoagulants may slightly adjust anticoagulant effect.

Side effects:

1. Common side effects include flushing of face and skin, gastrointestinal discomfort, nausea and mild itching.

2. Rare adverse reactions include liver function abnormality, myalgia and hypoglycemia.

Important Notice

This product should be administered only by qualified healthcare professionals in accordance with the approved prescribing information and local clinical guidelines. Dosage and administration may vary depending on patient condition, indicatiaon, and regional regulatory requirements.

Packaging & Shipping

Packaging

Original manufacturer’s packaging with secure export carton. Customized export packaging is available upon request.

Shipping Methods

Express Courier (EMS, DHL, FedEx, UPS), Air Freight, and Sea Freight. Cold-chain transportation is available for products requiring temperature-controlled logistics.

Export Support